跳至主要内容
临床试验/NCT02710786
NCT02710786招募中不适用

Long-term Resolution of Comorbidites After Gastric Bypass

Uppsala University1 个研究点 分布在 1 个国家目标入组 25,000 人开始时间: 2007年5月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
25,000
试验地点
1
主要终点
Change in comorbid conditions, as defined by use of pharmacological treatment

研究概览

简要总结

To evaluate effect on comorbid disease and weight loss in the long-term (>five years) after Roux-en-Y gastric bypass (RYGB) surgery for severe obesity.

详细描述

Individuals with severe obesity frequently have comorbid diseases, e.g. diabetes, hypertension, hyperlipidemia, and sleep apnea. We will study the remission rate and weight loss in the long-term (10 years) after Roux-en-Y gastric bypass (RYGB) surgery in a nationwide large group of patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Registered individuals in Scandinavian Obesity Surgery Registry (SOReg) having had gastric bypass

排除标准

  • All other operations

结局指标

主要结局

Change in comorbid conditions, as defined by use of pharmacological treatment

时间窗: 10 years

Remission of diabetes mellitus, hypertension, dyslipidemia, and depression as defined by use of pharmacological treatment, and sleep apnea as defined by use of CPAP. Data will be collected from SOReg.

次要结局

  • Weight loss(10 years)
  • BMI loss(10 years)
  • Number of patients with pathological laboratory data (corresponding to the studied comorbid conditions)(10 years)

研究者

发起方
Uppsala University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Comorbidity After Gastric Bypass | 临床试验